You are here

XBB COVID vaccine estimated effective rate: 63% to 68% against more severe illness in kids

Primary tabs

Fri, 2024-12-13 11:41 — mike kraft

XBB COVID vaccine estimated to be 63% to 68% effective against more severe illness in kids The adjusted effectiveness of the updated Pfizer/BioNTech COVID-19 XBB vaccine in the 2023-24 US respiratory virus season was 68% and 63% against hospitalization or emergency department (ED) or urgent-care visits among children aged 5 to 11 years and 12 to 17 years, respectively, with an overall effectiveness for both age-groups of 65%, a Kaiser Permanente Southern California (KPSC)-led research team estimates. CIDRAP

Country / Region Tags:

General Topic Tags:

Disease Prevention

Problem, Solution, SitRep, or ?:

Situation Report

Groups this Group Post belongs to:

Medical - global

- Private group -

Log in or register to post comments

Page loaded in 0.500 seconds.